After more than three billion doses, the Oxford-AstraZeneca Covid vaccine is being withdrawn. AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision.
The firm's application to withdraw the vaccine was made on ... The Serum Institute of India (SII), which produced AstraZeneca's COVID-19 vaccine under the brand name Covishield, stopped ...
AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision. It said the rise of new coronavirus variants meant demand had shifted to the newer updated vaccines.
The new development follows the company’s voluntary withdrawal of marketing authorisation for the vaccine in the European Union. Credit: rarrarorro / Shutterstock.com. AstraZeneca has begun the global ...
The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide ... The application to withdraw the vaccine was made on March 5 and came into effect on Tuesday. Similar applications will ...
Social media posts falsely claim AstraZeneca admitted rare blood clot risk in court documents. Learn the truth about the ...
The new Novavax XBB.1.15 vaccine appears to have been knocked back for approval by the Therapeutic Goods Administration.
県内の新型コロナウイルス感染症例発生状況等 令和5年5月8日に、新型コロナウイルス感染症が「5類感染症」に位置づけられ、医療機関等の届出による毎日の「全数把握」から、県内約120か所における週1回の「定点把握」に移行しました。 これに伴い、県内 ...
厚生労働省は5月31日、全国に約5千ある定点医療機関に20~26日に報告された新型コロナウイルスの新規感染者数は計1万6554人で、1定点あたり3・35 ...